• 08: Antibody Response to RSV Vaccines in Immunocompromised Adults

  • Jan 17 2025
  • Length: 12 mins
  • Podcast

08: Antibody Response to RSV Vaccines in Immunocompromised Adults

Listen for free

View show details

  • Summary

  • This study investigates the antibody response to respiratory syncytial virus (RSV) vaccines in immunocompromised individuals. Researchers measured antibody levels in a cohort of immunocompromised adults after receiving either an adjuvanted or non-adjuvanted RSV vaccine. Results showed heterogeneous antibody responses, with a significant portion not achieving seroconversion or a high-titer neutralization threshold. The adjuvanted vaccine showed better results. Study limitations included a small sample size and lack of cellular data. The findings suggest a need for further investigation into optimizing RSV vaccination strategies for immunocompromised populations.


    Created with NotebookLM by Google so there may be mistakes and/or errors.


    PMID: 39786402

    Karaba AH, Hage C, Sengsouk I, et al. Antibody Response to Respiratory Syncytial Virus Vaccination in Immunocompromised Persons. JAMA 2024.
    Show more Show less
Show more Show less

What listeners say about 08: Antibody Response to RSV Vaccines in Immunocompromised Adults

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available